Related Experiment Video
Updated: Nov 19, 2025

Standardized Technique of Aortic Valve Re-implantation for Valve-sparing Aortic Root Replacement
Published on: December 11, 2017
Outcome of valve sparing root replacement for diverse indications
Antti Huuskonen1, Johanna Valo1, Markku Kaarne1
1Department of Cardiac Surgery, Heart and Lung Center, Helsinki University Hospital, Helsinki, Finland.
Valve-sparing aortic root replacement (VSRR) shows excellent mid-term outcomes for diverse patient groups, including those with bicuspid aortic valve (BAV) and connective tissue disorders (CTD). Survival and freedom from reoperation or significant aortic insufficiency were high, indicating VSRR
Area of Science:
- Cardiovascular Surgery
- Aortic Valve Disease
- Congenital Heart Disease
Background:
- Valve-sparing aortic root replacement (VSRR) is a complex procedure with varying outcomes depending on patient complexity.
- Understanding mid-term results in diverse patient cohorts, including those with bicuspid aortic valve (BAV), connective tissue disorders (CTD), aortic dissection (AD), and congenital heart disease (CHD), is crucial for surgical decision-making.
Purpose of the Study:
- To evaluate the mid-term outcomes of VSRR using the reimplantation technique in a mixed-risk patient population.
- To assess survival rates, freedom from aortic valve replacement (AVR), and freedom from significant aortic insufficiency (AI) or reoperation.
- To identify potential risk factors for adverse outcomes in patients undergoing VSRR.
Main Methods:
- A retrospective analysis of 174 patients who underwent VSRR with the reimplantation technique between 2005 and 2017.
- Data collected included patient demographics, preoperative conditions (BAV, CTD, AD, CHD, AI), concomitant aortic valve repair, and follow-up events.
- Kaplan-Meier survival analysis and Cox regression were used to evaluate outcomes and risk factors.
Main Results:
- Zero 30-day mortality was observed.
- Five-year estimates showed 96% survival, 98% freedom from AVR, and 97% freedom from >= moderate AI or reoperation.
- No significant differences in outcomes were found based on the presence of BAV, CTD, leaflet repair, or preoperative AI.
Conclusions:
- VSRR demonstrates excellent mid-term efficacy and safety in a diverse patient cohort, even in centers with limited annual VSRR volume.
- Patient-specific factors like BAV, CTD, or the need for valve repair did not negatively impact long-term outcomes.
- VSRR is a viable and effective option for managing aortic root pathology across a broad spectrum of patients.
More Related Videos
12:17Full-root Aortic Valve Replacement by Stentless Aortic Xenografts in Patients with Small Aortic Roots
Published on: May 21, 2017
05:31Transcatheter Pulmonary Valve Replacement from Autologous Pericardium with a Self-Expandable Nitinol Stent in an Adult Sheep Model
Published on: June 8, 2022